Elevance Health, Inc. 8-K

What Happened
Elevance Health, Inc. (ELV) filed an 8-K on April 22, 2026 (Item 2.02) announcing it issued a press release reporting its financial results for the quarter ended March 31, 2026. The press release is furnished as Exhibit 99.1 to the filing and is incorporated by reference; the filing also includes the Inline XBRL cover page (Exhibit 104). The 8-K includes the company’s standard forward‑looking statements caution.

Key Details

• Filing date: April 22, 2026 (Form 8-K, Item 2.02).
• Period covered: Quarter ended March 31, 2026 (Q1 2026).
• Press release: Furnished as Exhibit 99.1 (contains the detailed quarterly results).
• Interactive data: Exhibit 104 (Cover Page Interactive Data File, Inline XBRL).

Why It Matters
This 8-K notifies investors that Elevance has publicly reported its Q1 2026 earnings and related metrics; investors should review Exhibit 99.1 (the press release) and the XBRL data for specific figures on revenue, earnings, guidance, and other performance metrics that can affect the stock. The filing’s forward‑looking statements section highlights risks and reminds investors to consider the company’s SEC filings when evaluating future expectations.